Authors


Stacey Ness, PharmD, MSCS, AAHIVP

Latest:

Growth Hormone Therapy: A Specialty Pharmacy Overview

Growth hormone deficiency in children and adults is a disease state that utilizes growth hormone therapy. Here is what specialty pharmacists can do for these patients and what they should know about these conditions.


Michelle E. Skornicki, MPH

Latest:

Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving Chemotherapy

For US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.


Mary Bridgeman, PharmD, BCPS, BCGP

Latest:

Diabetic Foot Care

Patient education and understanding the relationship between hyperglycemia, peripheral vascular disease, neuropathy, and foot complications are essential to reduce the potential for foot injury, ulceration, or amputation.


Nicodemo “Nick” Calla, RPh, JD

Latest:

Accountable Care Organizations: Pharmacy on the Front Lines

Specialty pharmacy is at the forefront of providing the team-based care and patient counseling now being sought in the developing accountable care organization model.


Daniel Shifrin

Latest:

Celebrating 45 Years of Pharmacy Stamps

This month marks the 45th anniversary of the introduction of the pharmacy stamp. A collector of the commemorative envelopes of first-day covers ruminates on his hobby.


John J. Barron, PharmD

Latest:

Analyzing the Impact of Different Value-Based Insurance Design Programs

Total 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.



Phillip S. Owen, PharmD, BCPS

Latest:

Postsurgical Pain Control

Data from large survey reports suggest that more than 80% of Americans who undergo surgery experience some level of postsurgical pain.


Danmin Lu, Doctor of Pharmacy Candidate

Latest:

Zooming Through the Pandemic: NSU Virtual AMCP Student Chapter

There are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.



Brandeis Seymore, RPh, MPBA Candidate

Latest:

Value Based Contracts for Specialty Pharmacy

In an era of high-priced drugs, health care stakeholders continue to explore alternative pricing models that focus on the concept of value-based drug purchasing models.


Anne Runyon

Latest:

Oncology Therapy Choices Under Greater Scrutiny From Payers

The cost of oncology treatment is high and rising in the United States.


Michael Bartholow, PharmD

Latest:

Top 200 Drugs of 2010

This close look at the top 200 drugs of 2010 by sales and prescriptions dispensed reveals the story of a pharmaceutical market in flux.


TJ Sayre, PharmD

Latest:

Antidepressant Discontinuation: What the Tertiary Databases and Package Insert Tells You

Discontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.


Kelly L. Matson, PharmD

Latest:

Detecting Signs of Opioid Abuse and Treating the Addiction

Knowing the warning signs and establishing trust are crucial to identifying and treating the opioid abuser.



James Notaro, BSPharm, MS, RPh, PhD

Latest:

Medication Reconciliation: 2013 and Beyond

The entrepreneurial pharmacist has the responsibility of creating the value proposition for providing medication reconciliation.



Steve Arnoff

Latest:

Statement by Ralph G. Neas, President and CEO, GPhA, Regarding 21st Century Cures

GPhA commends House Energy and Commerce Committee Chairman Fred Upton, Ranking Member Frank Pallone, Rep. Diana DeGette, Health Subcommittee Chair Joe Pitts, and Health Subcommittee Ranking Member Gene Green for their bipartisan leadership around fostering the development of new cures.


Matthew Weathers, PharmD

Latest:

A Diabetes Success Story

One of the most enduring lessons from my training in the care of geriatric patients is the following maxim: “Treat every new symptom like a (possible) drug adverse effect until proven otherwise.”


Cherylann Gregory, RN, BSN

Latest:

A Tribute to Oncology Nurses

Oncology nurses help improve patient outcomes through their dedication and expertise.


Karen A. Fitzner, PhD

Latest:

Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing Barriers

This paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.


Frank J. Nice, RPh, BSPharm, MSPharm, MPA, DPA, CPHP

Latest:

Depression and Breast-Feeding: Medication Use

Knowledgeable pharmacists can positively influence mothers who are depressed as well as women who want to breast-feed but do not because of medication use.



James A. Jorgenson, RPh, MS, FASHP

Latest:

Rethinking Pharmacy Employee Engagement

While often overlooked, employee engagement is a key element in determining whether a hospital, health system, or pharmacy service can effectively meet its patient access, patient quality, and organizational financial demands.



Jan E. Berger, MD, MJ

Latest:

Laser Focused in Drug Usage

A model of formulary decision making that evaluates medications based on usage could have significant implications for providers, consumers, and manufacturers.


Clarence D. Moore, PharmD, BCPS

Latest:

Decongestants and Hypertension: Dangerous Together

Nearly 33% of adults in the United States have the typically symptomless disease known as hypertension.


Bruce Parsons, MD, PhD

Latest:

Trends Associated with Implementing and Lifting a Pregabalin Step Therapy Policy

This study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.